Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer

Platelet-lymphocyte ratio (PLR) is a hematological parameter which is investigated as a biomarker for prognosis in patients with breast cancer. Due to the controversial results from previous studies, we performed a meta-analysis. Databases of PubMed, Embase and Web of Science were searched to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yanyun, Si, Wen, Sun, Qiong, Qin, Boyu, Zhao, Weihong, Yang, Junlan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352031/
https://www.ncbi.nlm.nih.gov/pubmed/27906679
http://dx.doi.org/10.18632/oncotarget.13714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352031/
https://www.ncbi.nlm.nih.gov/pubmed/27906679
http://dx.doi.org/10.18632/oncotarget.13714

Ejemplares similares